AWM Investment Company’s Syros Pharmaceuticals, Inc. Common Stock SYRS Stock Holding History

AWM Investment Company’s Portfolio SYRS Stock Details SYRS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-6,500	Closed	-$632K	–	100
2017 Q4	$632K	Sell	6,500 -6,000	-48%	-$806K	0.12%	87
2017 Q3	$1.84M	Buy	12,500 +338	+3%	+$63.6K	0.32%	67
2017 Q2	$1.96M	Buy	12,162 +7,407	+156%	+$1.16M	0.35%	65
2017 Q1	$757K	Hold	4,755	–	–	0.14%	80
2016 Q4	$578K	Hold	4,755	–	–	0.11%	87
2016 Q3	$660K	Buy	+4,755	New	+$604K	0.12%	89

Other funds holding SYRS

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

AWM Investment Company's SYRS Position: Q1 2018 in Review

AWM Investment Company sold out of Syros Pharmaceuticals, Inc. Common Stock (SYRS) in Q1 2018, closing a stake of 6,500 shares — an estimated $632K sold.

AWM Investment Company first reported a position in SYRS in Q3 2016 and held it in 6 quarters. The position peaked at $1.96M in Q2 2017. 57 funds tracked by Wall St. Rank hold SYRS as of Q1 2018.

AWM Investment Company reported no remaining Syros Pharmaceuticals, Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
AWM Investment Company sold 6,500 Syros Pharmaceuticals, Inc. Common Stock shares in Q1 2018, an estimated $632K.
AWM Investment Company first reported a position in Syros Pharmaceuticals, Inc. Common Stock in Q3 2016 and held it in 6 quarters.
AWM Investment Company's Syros Pharmaceuticals, Inc. Common Stock position peaked at $1.96M in Q2 2017.
57 funds tracked by Wall St. Rank held Syros Pharmaceuticals, Inc. Common Stock as of Q1 2018.

Based on AWM Investment Company's 13F filing for Q1 2018, filed 10 May 2018.